BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8799580)

  • 1. Prevention by the 5-HT3 receptor antagonist, ondansetron, of morphine-dependence and tolerance in the rat.
    Hui SC; Sevilla EL; Ogle CW
    Br J Pharmacol; 1996 Jun; 118(4):1044-50. PubMed ID: 8799580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT3 antagonists reduce morphine self-administration in rats.
    Hui SC; Sevilla EL; Ogle CW
    Br J Pharmacol; 1993 Dec; 110(4):1341-6. PubMed ID: 8306073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    Eur J Pharmacol; 1997 Dec; 340(2-3):111-9. PubMed ID: 9537805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors.
    Cui R; Suemaru K; Li B; Kohnomi S; Araki H
    Eur J Pharmacol; 2009 May; 609(1-3):74-7. PubMed ID: 19374878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
    Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
    J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice.
    Mori T; Komiya S; Ohya J; Uzawa N; Sugiyama K; Saitoh Y; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2014 Oct; 740():160-7. PubMed ID: 25034809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voluntary oral morphine self-administration in rats: effect of haloperidol or ondansetron.
    Borg PJ; Taylor DA
    Pharmacol Biochem Behav; 1994 Mar; 47(3):633-46. PubMed ID: 8208784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice.
    Ninan I; Kulkarni SK
    Brain Res; 2000 Sep; 876(1-2):215-9. PubMed ID: 10973613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.
    Suzuki T; Ise Y; Mori T; Misawa M
    Life Sci; 1997; 61(16):PL249-54. PubMed ID: 9353175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine preference in rats previously morphine dependent.
    Dai S; Hui SC; Ogle CW
    Pharmacol Res Commun; 1984 May; 16(5):495-511. PubMed ID: 6539922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats.
    Rawls SM; Baron DA; Kim J
    Behav Pharmacol; 2010 Mar; 21(2):161-4. PubMed ID: 20215965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
    Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
    Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse.
    Moulédous L; Díaz MF; Gutstein HB
    Pharmacol Biochem Behav; 2007 Nov; 88(1):39-46. PubMed ID: 17764731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.